Dx Deals: New Premerger Regulations Could Slow Down Pace of Transactions
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
The new rules, which were approved by the FTC in October and will go into effect in mid-January, aim to put a damper on consolidation
From - Laboratory Industry Report
Strategic alliance rather than M&A remains the preferred form of strategic interaction in the lab industry…
From - Laboratory Industry Report
As usual, the Big 3 of Abbott, Quest and LabCorp were the driving force of M&A activity in the diagnostics industry in the first half of 2017…
From - Laboratory Industry Report
After a relatively slow March and April, business has picked up noticeably in May, June and July with deal volume increasing across all…
From - Laboratory Industry Report
Deal volume in May and June was noticeably higher, especially in terms of M&A activity. There was more global activity over the current than…
From - Laboratory Industry Report
The big story of April wasn't any particular new deal but the apparent resolution of an old one—the Abbott-Alere merger. Deal volume remained…
From - Laboratory Industry Report
Although several companies secured favorable diagnostic coverage determinations in March, the big winner was Vermillion, manufacturer of the…
From - Laboratory Industry Report
In the early months of 2017, the diagnostic industry has seen several strategic alliances develop.
Among the most active companies…